期刊文献+

多种免疫抑制剂联合应用于单倍体骨髓移植 被引量:2

Immune-reconstitution following HLA haplotype related T-cell undepleted allogeneic bone marrow transplantation
下载PDF
导出
摘要 目的 :观察多种免疫抑制剂联合使用后半相合未去T细胞骨髓移植术后患者免疫功能的恢复情况。方法 :38例白血病患者接受HLA 2~ 3个位点不匹配的亲缘骨髓移植 ,用ATG、CD2 5抗体、CSA、MTX、MMF预防移植物抗宿主病 (GVHD) ,定期对受者在移植术后 1、3、6、12、18个月的外周血淋巴细胞亚群和血清免疫球蛋白进行检测。结果 :移植术后 1个月患者淋巴细胞各亚群均明显下降 ,CD4 + T最明显 ,CD4 + T细胞绝对数在 +6月达 2 0 0个 /μl,导致CD4 /CD8持续倒置 ,在移植后 18个月才逐渐恢复。CD3+ 、CD8+ 、CD19+ B细胞计数在BMT后的 6~ 12个月基本恢复。因常规输注丙种球蛋白BMT后IgG一直正常 ,IgM和IgA分别在移植后 6~ 9个月和 18个月恢复。结论 :单倍体相合骨髓移植后 1年患者免疫功能处于低下状态 ,CD4 + T和IgA恢复最慢 ,CD4 + 细胞百分比和绝对值持续的低下 ,CD4 /CD8持续倒置是移植后感染高发的原因 。 Objective:To evaluated immune state of the patients after using several immunosuppressive drugs to reduce acute GVHD in T-cell undepleted haploidentical bone marrow transplantation (Allo-BMT).Method:Thirty-eight patients with leukemia received Allo-BMT from HLA two or three loci mismatched related donors, ATG, CD25 monoclonal antibody, CsA, MTX, and mycophenolate mofetil (MMF) were combined for GVHD prophylaxis. Using Flow cytometry (FCM) to detect lymphocyte subsets and to detect the level of Ig of some recipients at 1, 3, 6, 12, 18 months after BMT.Result:All lymphocyte subsets counts were significantly decreased in the first month after BMT, CD4 + T cell were lower significantly throughout the 18 months post-BMT, the absolute number of CD4 + T cell count reached to 200/ul at 6 months post-BMT, and CD4/CD8 ratios persistently reversed at 18 months after BMT. CD8 +T cell, CD3 + cell and CD19 +B cell counts recovered at 6~12 months after BMT. With regular IV Ig, the serum levels of IgG were normal post-BMT, the levels of IgM and IgA reached to normal level at 6~9 months and 18 months respectively after BMT.Conclusion:The recipents remained immunodeficiency throughout 1 years post HLA haplotype match and T-cell undepleted Allo-BMT. CD4 +T cell and IgA recovered significantly slowly, especially the percent and the absolute number of CD4 +T cell were lower significantly throughout the 18 months post-BMT, persistently CD4/CD8 ratios reversed at 18 months following BMT. It maybe cause high-risk infectons. It is important to give patient support care.
出处 《临床血液学杂志》 CAS 2005年第1期7-10,共4页 Journal of Clinical Hematology
关键词 白血病 单倍体骨髓移植 免疫重建 BMT, allogeneic Haplotype Immun reconstitution
  • 相关文献

参考文献11

  • 1纪树荃,陈惠仁,王恒湘,阎洪敏,刘静,薛梅,朱玲.单倍体相合骨髓移植中急性移植物抗宿主病预防新方案的临床研究[J].中华血液学杂志,2003,24(8):416-419. 被引量:29
  • 2Godthelp B C,van Tol M J,Vossen J M,et a1.T—cell immune reconstitution in pediatric 1eukemla patienta after allogeneic bone marrow transplantation with T—cell-depleted or unmanipulated grafts:evaluation of overall and antigen specific T—cell repertoirs.Blood,1999,94:4358—4436.
  • 3Passweg J R,Rowlings P A,Horowitz M M.Related donor bone marrow transplantation for chronic myelogenous leukemia.H ematology/Oncology Clinical of North America,1998,12,1:81—92.
  • 4Norhagen G E,Engstrom P E,Bjorstrand B,et a1.Salivary and serum immunglobulins in rcipents of transplanted allogeneic and autulogous bone marrow.BMT,1994,14:229—234.
  • 5Nasman I,Lundkvist I.Oligoclonal dominance of immunglobulin VH3 rearangements following allogeneic bong marrow transplantation.BMT,1998,21:1223-1230.
  • 6Atkinson.Reconstitution of the haemopoietie and ommune system after bone marrow transplantation.Bone Marrow Transplant,1990,5:209—226.
  • 7Lamb L S,Gee A P,Henslee-Downey P J,er a1.Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell—depleted bone marrowtransplantation from partially mismatched relateddorors.BMT,1998,21:461—471.
  • 8Maury S,Mary J Y,Rabian C,te a1.Prolonged Immune deficiency following allogeneic stem cell transplantation:risk factors and complications Inadult patients.Br—J—haematol,2001,115:630—641.
  • 9Ji shu—quan,Chen Hui—Ren,Xun Chang—Qing,et a1.The effect of G-CSF—stimulated donor marrOW on engraftment and incidence of graft—versus—host disease in allogeneic bone marrow transplantation.Clinical Transplantation,2001,15:317—323.
  • 10Aversa F,Tabilio A,Velardi A,et a1.Treatment of hish risk acute leukemia with T cell—depleted stem cells from related donor with one full mismatched HI。A haplotype.N Engl J Med,1998,339:1186—1193.

二级参考文献10

  • 1Krenger W, Cooke KR, Crawford JM,et al. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versushost disease. Transplantation, 1996, 62:1278-1285.
  • 2Tayebi H, Kuttler F, Saas P, et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol,2001, 29: 458-470.
  • 3Mineishi S, Longo WL, Atkinson ME, et al. Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplant, 1999,23:1217-1222.
  • 4Amlot PL, Rawlings E, Femando ON, et al. Prolonged action of a chimeric interleukin-2 receptor(CIY25) monoclonal antibody used in cadaveric renal transplantation. Transplantation, 1995, 60:748-7.56.
  • 5Harris DT, Sakiestewa D, Lyons C, et al. Prevention of graft-versus-host disease(GVHD) by elimination of recipient-reaction donor T cell with recombinant toxins that target the interleukin 2 (IL-2) receptor. Bone Marrow Transplant, 1999, 23:137-144.
  • 6Aversa F, Tabilio A, Velardi A, et al. Treatment of high risk acute leukemia with T cell-depleted stem cells from related donor with one full mismatched HLA haplotype. N Engl J Med, 1998, 339:1186-1193.
  • 7Ji SQ, Chen HR, Xun CQ, et al. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation. Clin Transplant, 2001, 15: 317-325.
  • 8Ji SQ, Chen HR, Wang HX, et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte-colony stimulating factor (Lenograstim) donor marrow priming in patients with chronic myelogenous leukemia(CML). Biol Blood Marrow Transplant, 2002,8:261-267.
  • 9Ji SQ, Chen HR, Wang HX, et al. G-CSF primed haploidentical marrow transplantation without ex-vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplant,2002, 30:861-866.
  • 10Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant huamn granulocyte colony-stimulating factor. Blood, 1995,85 : 1655-1658.

共引文献28

同被引文献29

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部